Andrey Finegersh1, Gregg E Homanics2. 1. University of Pittsburgh, Departments of Anesthesiology and Pharmacology & Chemical Biology, 6060 Biomedical Science Tower-3, 3501 Fifth Avenue, Pittsburgh, PA 15261, United States. 2. University of Pittsburgh, Departments of Anesthesiology and Pharmacology & Chemical Biology, 6060 Biomedical Science Tower-3, 3501 Fifth Avenue, Pittsburgh, PA 15261, United States. Electronic address: homanicsge@anes.upmc.edu.
Abstract
BACKGROUND: With advances in cell capture, gene expression can now be studied in neuronal subtypes and single cells; however, studying epigenetic mechanisms that underlie these changes presents challenges. Moreover, chromatin immunoprecipitation (ChIP) protocols optimized for low cell number do not adequately address technical issues and cell loss while preparing tissue for fluorescence activated cell sorting (FACS). Developing a reliable FACS-ChIP protocol without the need for pooling tissue from multiple animals would enable study of epigenetic mechanisms in neuronal subtypes. METHODS: FACS was used to isolate dopamine 1 receptor (D1R) expressing cells from the nucleus accumbens (NAc) of a commercially available BAC transgenic mouse strain. D1R+ cells were used to study gene expression as well as histone modifications at gene promoters using a novel native ChIP protocol. RESULTS: Isolated cells had enrichment of the dopamine 1 receptor (D1R) mRNA and nearly undetectable levels of GFAP and D2R mRNA. ChIP analysis demonstrated the association of activating or repressive histone modifications with highly expressed or silent gene promoters, respectively. COMPARISON WITH EXISTING METHODS: The ChIP protocol developed in this paper enables characterization of histone modifications from ∼30,000 FAC-sorted neurons. CONCLUSIONS: We describe a one day FACS-ChIP protocol that can be applied to epigenetic studies of neuronal subtypes without pooling tissue.
BACKGROUND: With advances in cell capture, gene expression can now be studied in neuronal subtypes and single cells; however, studying epigenetic mechanisms that underlie these changes presents challenges. Moreover, chromatin immunoprecipitation (ChIP) protocols optimized for low cell number do not adequately address technical issues and cell loss while preparing tissue for fluorescence activated cell sorting (FACS). Developing a reliable FACS-ChIP protocol without the need for pooling tissue from multiple animals would enable study of epigenetic mechanisms in neuronal subtypes. METHODS: FACS was used to isolate dopamine 1 receptor (D1R) expressing cells from the nucleus accumbens (NAc) of a commercially available BAC transgenicmouse strain. D1R+ cells were used to study gene expression as well as histone modifications at gene promoters using a novel native ChIP protocol. RESULTS: Isolated cells had enrichment of the dopamine 1 receptor (D1R) mRNA and nearly undetectable levels of GFAP and D2R mRNA. ChIP analysis demonstrated the association of activating or repressive histone modifications with highly expressed or silent gene promoters, respectively. COMPARISON WITH EXISTING METHODS: The ChIP protocol developed in this paper enables characterization of histone modifications from ∼30,000 FAC-sorted neurons. CONCLUSIONS: We describe a one day FACS-ChIP protocol that can be applied to epigenetic studies of neuronal subtypes without pooling tissue.
Authors: Angela R Ozburn; Edgardo Falcon; Alan Twaddle; Alexandria L Nugent; Andrea G Gillman; Sade M Spencer; Rachel N Arey; Shibani Mukherjee; James Lyons-Weiler; David W Self; Colleen A McClung Journal: Biol Psychiatry Date: 2014-08-13 Impact factor: 13.382
Authors: Sanya Fanous; Danielle H Guez-Barber; Evan M Goldart; Regina Schrama; Florence R M Theberge; Yavin Shaham; Bruce T Hope Journal: J Neurochem Date: 2012-11-21 Impact factor: 5.372
Authors: Shiaoching Gong; Chen Zheng; Martin L Doughty; Kasia Losos; Nicholas Didkovsky; Uta B Schambra; Norma J Nowak; Alexandra Joyner; Gabrielle Leblanc; Mary E Hatten; Nathaniel Heintz Journal: Nature Date: 2003-10-30 Impact factor: 49.962
Authors: Alisa Mo; Eran A Mukamel; Fred P Davis; Chongyuan Luo; Gilbert L Henry; Serge Picard; Mark A Urich; Joseph R Nery; Terrence J Sejnowski; Ryan Lister; Sean R Eddy; Joseph R Ecker; Jeremy Nathans Journal: Neuron Date: 2015-06-17 Impact factor: 17.173
Authors: Gregor D Gilfillan; Timothy Hughes; Ying Sheng; Hanne S Hjorthaug; Tobias Straub; Kristina Gervin; Jennifer R Harris; Dag E Undlien; Robert Lyle Journal: BMC Genomics Date: 2012-11-21 Impact factor: 3.969
Authors: Peter J Hamilton; Dominika J Burek; Sonia I Lombroso; Rachael L Neve; Alfred J Robison; Eric J Nestler; Elizabeth A Heller Journal: Neuropsychopharmacology Date: 2017-05-02 Impact factor: 7.853
Authors: Alberto J López; Thekla J Hemstedt; Yousheng Jia; Philip H Hwang; Rianne R Campbell; Janine L Kwapis; Andre O White; Om Chitnis; Vanessa M Scarfone; Dina P Matheos; Gary Lynch; Marcelo A Wood Journal: Neuropharmacology Date: 2019-04-15 Impact factor: 5.250